ArticleJAMA network open2023

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab.

Emily S Lebow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.